Feb 24, 2026GLP-1 Agonists and Aging: Metabolic Benefits, Cardiovascular Evidence, and Longevity ImplicationsGLP-1 receptor agonists like semaglutide have demonstrated cardiovascular and metabolic benefits beyond weight reduction. This review covers the mechanistic basis, major trial evidence, and the open questions about their role in longevity medicine.
Feb 24, 2026Grip Strength as a Longevity Biomarker: Evidence and InterventionsGrip strength is one of the most powerful and accessible biomarkers of biological aging, predicting cardiovascular events, hospitalization, and all-cause mortality more reliably than many clinical tests. This article covers the mechanisms, evidence, and interventions.
Feb 24, 2026Inflammaging: Chronic Low-Grade Inflammation in Aging, Causes, and Intervention EvidenceInflammaging — the chronic low-grade inflammatory state that accumulates with age — is now recognized as a driver of virtually every major age-related disease. Senescent cells, gut dysbiosis, and visceral fat are the primary sources. Targeted interventions address the root causes, not just the biomarkers.
Feb 24, 2026Kidney Health and Aging: GFR Decline, Protein Intake, and Renoprotective StrategiesGFR declines ~1 mL/min/year after age 40. In early-stage CKD, protein restriction, blood pressure control, and avoiding nephrotoxic supplements (high-dose oxalate, aristolochic acid) are the primary levers. Potassium citrate and omega-3 have supportive evidence.
Feb 24, 2026Longevity Biomarkers: What to Test, What the Results Mean, and How to Track ProgressBiological age testing spans conventional labs (HbA1c, CRP, lipids) to newer epigenetic clocks and proteomic aging scores. Most conventional biomarkers are actionable today; epigenetic clocks measure biological vs. chronological age but their clinical utility for intervention-guiding remains limited. A pragmatic panel of validated tests provides meaningful signal about longevity trajectory.
Feb 24, 2026Longevity Biomarkers: What to Track, How Often, and What the Evidence Says They MeanNo single biomarker captures biological age, but a panel of accessible blood and functional markers — HbA1c, hs-CRP, homocysteine, IGF-1, DHEA-S, grip strength, and VO2 max — provides a practical composite picture. Epigenetic clocks offer precision but limited actionability at current cost.
Feb 24, 2026Menopause and Perimenopause: Supplement Evidence for Hot Flashes, Bone Loss, and Cognitive SymptomsThe menopausal transition accelerates bone loss, cognitive change, sleep disruption, and cardiovascular risk. Supplement evidence varies sharply: isoflavones have modest hot flash data; calcium and vitamin D are well-supported for bone; magnesium helps sleep. Black cohosh is used widely but evidence is mixed.
Feb 24, 2026Polyphenol Stack Synergy: Quercetin, Resveratrol, Curcumin, and EGCG Combined EvidenceQuercetin, resveratrol, curcumin, and EGCG activate overlapping pathways — NRF2, SIRT1, AMPK, and NFkB inhibition. Stacking them is popular but evidence for synergistic human benefit is largely extrapolated from in vitro and animal models. This article assesses what stacking adds and what it does not.
Feb 24, 2026SIRT3 and Mitochondrial Integrity: NAD-Dependent Deacetylase, Caloric Restriction Mimicry, and ActivatorsSIRT3 is the primary mitochondrial sirtuin — a NAD-dependent deacetylase that regulates ATP synthesis, ROS detoxification, and fatty acid oxidation. Its activity declines with age and NAD+ depletion. Activators include honokiol, urolithin A, and exercise, though human trial data is thin.
Feb 24, 2026Testosterone Decline in Aging Men: Natural Interventions, Monitoring, and TRT ContextTestosterone declines ~1% per year after age 30 in men. Below clinical thresholds, symptoms include fatigue, sarcopenia, and cognitive fog. Lifestyle interventions (resistance training, sleep, zinc, vitamin D) have the best evidence for supporting endogenous production. Ashwagandha and fenugreek show modest RCT data.
Feb 24, 2026Vision and Age-Related Macular Degeneration: Lutein, Zeaxanthin, and AREDS2 EvidenceThe AREDS2 trial established lutein and zeaxanthin as replacements for beta-carotene in the AMD supplement formula, reducing progression risk by 25% in high-risk eyes. Dietary intake from dark leafy greens provides equivalent carotenoids. This article explains what the evidence supports and what it does not.
Feb 24, 2026VO2max and Cardiorespiratory Fitness: Why It Predicts Longevity and How to Improve ItVO2max is one of the strongest independent predictors of all-cause mortality. This review covers what VO2max measures, how it declines with age, and the training protocols with the best evidence for improving it.
Feb 24, 2026Zone 2 Training and Mitochondrial Health: Evidence for Endurance, Metabolic, and Longevity BenefitsZone 2 training — sustained low-intensity aerobic work — is the primary stimulus for mitochondrial biogenesis and fat oxidation capacity. This review covers how to define and perform zone 2, the evidence for its health and longevity benefits, and how it fits into a complete training program.
Feb 23, 2026Blood Sugar and Insulin Resistance: Supplement Protocol, Monitoring, and Evidence SummaryInsulin resistance precedes type 2 diabetes by years and independently drives cardiovascular risk, cognitive decline, and accelerated aging. Berberine, magnesium, alpha-lipoic acid, and chromium have the best evidence among supplements. This protocol integrates the strongest interventions with clear monitoring markers.
Feb 23, 2026Copper and Zinc Balance: Enzymatic Roles, Aging-Related Shifts, and Supplementation RisksCopper and zinc compete for absorption and must stay in balance. Zinc supplementation without copper co-dosing can induce copper deficiency, causing anemia and neurological symptoms. Aging shifts the Cu/Zn ratio and affects superoxide dismutase activity — monitoring both matters.
Feb 23, 2026Sedentary Behavior and Step Count in Aging: What the Evidence Says About Movement ThresholdsLow daily step count and prolonged sitting independently predict cardiovascular disease, metabolic dysfunction, and premature mortality. This article reviews the evidence thresholds and practical movement strategies for aging adults.
Feb 22, 2026Anemia and Iron Deficiency in Aging: Diagnosis, Causes, and Supplementation EvidenceAnemia affects 10–20% of adults over 65 and is independently associated with frailty, cognitive decline, and mortality. Iron deficiency is the most common cause but is often missed in older adults. Supplementation restores function when deficiency is confirmed — but iron excess is harmful and routine supplementation without deficiency is not indicated.
Feb 22, 2026Longevity Protocol for Men Over 50: Evidence-Based PrioritiesMen over 50 face accelerating cardiovascular, metabolic, and hormonal changes. This protocol covers the highest-leverage, evidence-based interventions for men in the second half of life.
Feb 22, 2026Vitamin E: Tocopherol vs Tocotrienol Forms, Antioxidant Evidence, and Supplementation RisksVitamin E encompasses eight molecules: four tocopherols and four tocotrienols. Synthetic dl-alpha-tocopherol dominates the supplement market but has underperformed in trials. Tocotrienols — especially delta and gamma forms — show more promising cardiovascular and neuroprotective signals.
Feb 21, 2026Gut Microbiome and Probiotics in Aging: Diversity Decline, Leaky Gut, and Evidence-Based InterventionsThe gut microbiome undergoes progressive diversity loss with age — a pattern linked to increased intestinal permeability, systemic inflammation, and reduced short-chain fatty acid production. Dietary fiber, fermented foods, and targeted probiotics have the best evidence for reversing these changes.
Feb 21, 2026Lactobacillus acidophilus: Gut Health, Immune Modulation, and Strain-Specific EvidenceLactobacillus acidophilus is one of the most studied probiotic species, with evidence spanning IBS symptom relief, immune modulation, and cholesterol reduction. Strain specificity matters enormously — not all L. acidophilus products produce identical effects.
Feb 21, 2026Longevity Protocol for Women Over 50: Evidence-Based PrioritiesPerimenopause and post-menopause mark a major metabolic and hormonal inflection point. This protocol covers the highest-leverage interventions for women over 50, grounded in current evidence.
Feb 20, 2026Creatine for Aging: Muscle Preservation, Cognitive Benefits, and Monohydrate vs AlternativesCreatine monohydrate is one of the most evidence-backed supplements for older adults, improving muscle strength, power output, and lean mass when combined with resistance training. Emerging evidence supports cognitive benefits — particularly working memory and processing speed. Monohydrate remains superior to proprietary alternatives.
Feb 20, 2026Inulin and Prebiotic Fiber: Microbiome Diversity, GLP-1, and Metabolic BenefitsInulin-type fructans selectively feed Bifidobacterium and Lactobacillus species, raising SCFA production. Clinical trials show dose-dependent improvements in glycemic control, lipid profiles, and gut transit. Effective doses (10–20 g/day) frequently cause transient gas — gradual titration is essential.
Feb 19, 2026Apigenin and Sleep: Evidence, Mechanisms, and ProtocolApigenin is being studied for sleep support through GABA-related pathways, with early human data suggesting possible modest benefits and a generally favorable short-term tolerability profile.
Feb 19, 2026Berberine for Metabolic Health: Evidence from Human TrialsBerberine activates AMPK through mild mitochondrial Complex I inhibition, producing improvements in glucose metabolism and modest weight loss in meta-analyses of clinical trials.
Feb 19, 2026Fisetin and Senolytic Research: Human Data, Protocol Context, and LimitationsFisetin has a strong preclinical senolytic rationale, while human evidence remains early-stage with limited placebo-controlled outcome data.
Feb 19, 2026Glucosamine for Joints: Cartilage Evidence, Cardiovascular Signal, and Sulfate vs HydrochlorideGlucosamine sulfate has modest RCT evidence for slowing cartilage loss and reducing joint pain in knee osteoarthritis. An unexpected but consistent epidemiological signal links glucosamine use with lower cardiovascular mortality — the mechanism may involve AMPK activation.
Feb 19, 2026Lion's Mane and Cognitive Function: Mechanisms, Human Evidence, and ProtocolLion's Mane mushroom stimulates nerve growth factor production and has shown cognitive benefits in small randomized trials in older adults, with preclinical evidence stronger than human data.
Feb 19, 2026Resveratrol and Memory Retention: Evidence from a 26-Week Randomized Trial in Older AdultsWitte et al. (2014) found statistically significant memory improvements in adults 50–75 taking 200 mg/day resveratrol for 26 weeks, alongside improved hippocampal connectivity and glucose metabolism. Sample size was small (n=46) and findings require replication.
Feb 19, 2026Spermidine and Autophagy: Human Evidence, Protocol Context, and UnknownsSpermidine has strong mechanistic and observational support, but randomized human outcome evidence remains limited and ongoing.
Feb 19, 2026Vitamin B12: Deficiency in Aging, Neurological Consequences, and Supplement Form EvidenceB12 deficiency affects 10–30% of adults over 50, largely due to reduced gastric acid and intrinsic factor. Deficiency causes irreversible neurological damage if uncorrected. Methylcobalamin and adenosylcobalamin are preferred over cyanocobalamin for neurological applications. High-dose oral B12 can bypass intrinsic factor.
Feb 18, 2026CoQ10 and Mitochondrial Function: Age-Related Decline and Clinical EvidenceCoQ10 declines with age and statin exposure. Human evidence is strongest in heart failure and statin-associated muscle symptoms, while prevention use in healthy adults remains less certain.
Feb 18, 2026Dasatinib and Quercetin for Senolytic Therapy: Mayo Clinic Phase 2 Trial FindingsA Mayo Clinic Phase 2 trial tested dasatinib plus quercetin in 60 older women with low bone density, finding improved bone formation markers. Dasatinib is an FDA-approved cancer drug requiring physician supervision.
Feb 18, 2026Eleuthero (Siberian Ginseng): Adaptogen Evidence, Fatigue, and Comparison with RhodiolaEleuthero (Eleutherococcus senticosus) is one of the most studied adaptogens, with Soviet-era and modern research on fatigue, immune function, and physical performance. Evidence quality is moderate; its benefit profile overlaps with rhodiola but with a distinct safety profile.
Feb 18, 2026Partial Epigenetic Reprogramming for Vision Loss: Life Biosciences ER-100 TrialLife Biosciences received FDA clearance to begin the first human trial of partial epigenetic reprogramming using OSK Yamanaka factors delivered via AAV for glaucoma and NAION. Trial is in early stages; no human efficacy data exists yet.
Feb 18, 2026Gene Therapy for Telomere Biology Disorders: EXG-34217 Trial Results at Cincinnati Children'sEXG-34217, a gene therapy delivering functional TERT, showed telomere elongation and hematopoietic recovery in two patients with dyskeratosis congenita — a rare inherited disease, not general aging. Results published in NEJM Evidence.
Feb 18, 2026NMN vs NR vs Nicotinamide: First Direct Human Comparison of NAD+ PrecursorsA 2025 Nature Metabolism crossover trial directly compared NMN, NR, and nicotinamide in healthy adults. NMN and NR produced sustained blood NAD+ increases of 130–150%; nicotinamide produced only a transient 4-hour rise. Gut microbiome conversion was a key mechanistic finding.
Feb 18, 2026Rapamycin in Older Adults: PEARL Trial Findings on Dose, Sex Differences, and Body CompositionThe PEARL trial tested low-dose weekly rapamycin in healthy older adults. The primary endpoint — visceral fat reduction — was not met. Secondary analyses suggested lean tissue effects at higher doses in women, but these require confirmation in adequately powered trials.
Feb 18, 2026POLYCAD Trial: Spermidine Supplementation in Coronary Artery Disease — Design and Interim ContextThe POLYCAD trial is testing 24 mg/day spermidine in 187 older adults with coronary artery disease for 48 weeks. Trial completion is expected August 2026 — no efficacy results exist yet. Prior cohort data from Eisenberg et al. 2016 provides the rationale.
Feb 18, 2026Vitamin C: Immune Function, Collagen Synthesis, Antioxidant Evidence, and Megadose ClaimsVitamin C is essential for collagen hydroxylation, neutrophil function, and regeneration of other antioxidants including vitamin E. Deficiency is common in older adults and smokers. Supplementation shortens cold duration modestly; megadose claims for cancer and longevity are not supported by RCT evidence.
Feb 18, 2026Vitamin D3 and Telomere Attrition: Findings from the VITAL Randomized TrialA VITAL sub-study (n=1,054, 4 years, 2,000 IU/day vitamin D3) found reduced leukocyte telomere attrition in the vitamin D group versus placebo. Omega-3 showed no significant effect. Telomere length is a surrogate marker; clinical outcome implications are uncertain.
Feb 17, 2026Astragalus and TA-65: Telomerase Activation, Immune Aging, and Evidence LimitsAstragalus extract (specifically cycloastragenol/TA-65) is the only commercially available small molecule with credible telomerase activation evidence in humans. Effects on telomere length are small and inconsistent. Immune aging benefits are better supported.
Feb 17, 2026Caloric Restriction Mimetics in 2025: Multi-Pathway Geroprotectors Under Clinical EvaluationA 2025 Biogerontology review maps geroprotective compounds targeting AMPK, mTOR, and autophagy pathways. Most remain at biomarker endpoints; hard longevity data in humans is largely absent.
Feb 17, 2026Selenium: Thyroid Function, Antioxidant Enzymes, Cancer Prevention Evidence, and Toxicity RiskSelenium is an essential trace mineral and key component of glutathione peroxidase and selenoprotein P. It has the strongest evidence base in thyroid autoimmunity (Hashimoto's) and antioxidant enzyme function. The SELECT trial found no cancer prevention benefit from selenium in replete populations — and excess is toxic.
Feb 17, 2026SIRT3 Activators in Early Clinical Development: Mitochondrial Targets for AgingSIRT3 is a mitochondrial deacetylase linked to energy efficiency and oxidative stress resistance. Novel small-molecule SIRT3 activators are in preclinical development; human efficacy data does not yet exist.
Feb 17, 2026NAD+ Precursor Supplementation and Cognitive Fatigue: Mechanism and Human EvidenceNAD+ precursors reliably elevate blood NAD+ in humans and activate mitochondrial energy pathways. Whether this translates to clinically meaningful reductions in cognitive fatigue requires larger, longer trials.
Feb 16, 2026Collagen Peptides: Joint Pain, Skin Aging, Bone Density, and Bioavailability EvidenceHydrolyzed collagen peptides are absorbed as dipeptides and tripeptides that accumulate in cartilage, skin, and bone tissue. RCTs show meaningful joint pain reduction in osteoarthritis and sports-related joint discomfort. Skin hydration and elasticity benefits are well-replicated. Evidence for bone density is emerging.
Feb 16, 2026Phosphatidylcholine: Liver Health, Cognitive Aging, and Choline AdequacyPhosphatidylcholine is the dominant structural phospholipid in cell membranes and a major dietary choline source. It supports liver fat export, membrane integrity, and acetylcholine synthesis. Most adults are choline-insufficient; supplementation has meaningful implications for liver and brain aging.
Feb 15, 2026Magnesium L-Threonate: Brain Penetration, Synaptic Density, and Cognitive EvidenceMagnesium L-threonate (MgT) was developed specifically to cross the blood-brain barrier more effectively than other magnesium forms. Animal studies show increased synaptic density and memory improvement. Human trials are limited but show working memory and executive function benefits in older adults.
Feb 15, 2026Silymarin (Milk Thistle): Liver Protection, MASLD Evidence, and Bioavailability ChallengesSilymarin (the active complex of milk thistle) has antioxidant and anti-inflammatory effects on hepatocytes. Evidence supports modest liver enzyme reduction in MASLD, though poor water solubility limits standard extract absorption. Phytosome forms show better bioavailability.
Feb 14, 2026Carnosine: Glycation Buffering, Brain Aging, and Carnosinase VariabilityCarnosine is a dipeptide that buffers glycation and carbonyl stress, with additional evidence for neuroprotection. Oral carnosine is cleaved by carnosinase — tissue uptake varies significantly by carnosinase genotype, which affects individual response.
Feb 14, 2026Magnesium: Deficiency in Aging, Form Comparison, and Evidence for Sleep, Blood Pressure, and MuscleMagnesium is the fourth most abundant mineral in the body and cofactor for over 300 enzymes. Dietary insufficiency is widespread — over 50% of adults consume below the RDA. Supplementation improves sleep quality, blood pressure, and muscle function, with form choice determining tolerability and absorption.
Feb 14, 2026Supplement Cycling Protocols: Rapamycin, Senolytics, and Adaptogens — Evidence for Intermittent UseNot all supplements should be taken daily. Rapamycin is typically dosed weekly to preserve mTOR signaling windows. Senolytics (dasatinib + quercetin, fisetin) are used in short intermittent bursts. Even some adaptogens are cycled to prevent tolerance. This article maps the rationale and evidence for each.
Feb 13, 2026Alpha-Ketoglutarate and Aging: TET Enzyme Activity, Epigenetic Clocks, and Ca-AKG TrialsAlpha-ketoglutarate (AKG) is a TCA cycle intermediate that activates TET enzymes involved in DNA demethylation. The TRIIM-X trial using Ca-AKG reported a reduction in biological age markers. Evidence is preliminary but mechanistically credible.
Feb 13, 2026The Microbiome-Longevity Connection: Centenarian Studies, Gut Diversity, and Prebiotic StrategyCentenarian microbiome studies consistently show higher diversity, more short-chain fatty acid producers, and distinct bacterial profiles compared to age-matched controls. Dietary fiber remains the strongest intervention for diversity. This article maps what the longevity-microbiome evidence shows and what remains speculative.
Feb 13, 2026Omega-3 Fatty Acids: EPA, DHA, Cardiovascular Outcomes, and Cognitive Aging EvidenceEPA and DHA are the two clinically relevant omega-3 fatty acids. High-dose EPA (REDUCE-IT trial, 4 g/day icosapentaenoic acid) significantly reduced cardiovascular events. DHA drives brain structural benefits. Standard fish oil doses produce modest effects; high-dose prescription forms show stronger outcomes.
Feb 13, 2026How to Read Supplement Research: RCTs vs Observational Studies, Effect Size, and Conflicts of InterestMost supplement claims come from observational data or industry-funded trials. Understanding the difference between RCTs and cohort studies, what effect size means, how to spot funding bias, and where to find reliable reviews is essential for evidence-based decisions.
Feb 13, 2026Vitamin D Deficiency and Immune Function: Prevalence, Evidence, and Supplementation ProtocolVitamin D deficiency is common and associated with higher infection risk. Meta-analytic RCT evidence suggests supplementation can reduce acute respiratory infection risk, especially in deficient groups.
Feb 12, 2026Biomarker Testing Before Supplementing: B12, Vitamin D, Homocysteine, Ferritin, and CRPSupplementing without baseline testing is guesswork. Vitamin D, B12, folate, ferritin, homocysteine, and hs-CRP are the most actionable starting points. This guide explains what each test reveals, what ranges mean, and which supplements to prioritize based on results.
Feb 12, 2026Inflammation Resolution: Specialized Pro-Resolving Mediators, Omega-3 Metabolites, and Beyond SuppressionMost anti-inflammatory strategies suppress inflammation. Resolution is an active, distinct process mediated by specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins — derived from omega-3 fatty acids. Supporting resolution rather than just suppression may be the more effective long-term approach.
Feb 12, 2026TMG (Trimethylglycine): Methylation Support, Homocysteine Reduction, and Exercise EvidenceTMG (trimethylglycine/betaine) donates methyl groups to lower homocysteine and supports the methylation cycle alongside B12 and folate. It also shows consistent exercise performance benefits in multiple RCTs — a dual-purpose compound with a clean safety profile.
Feb 11, 2026Age-Specific Supplement Needs: Shifting Priorities from Your 40s to Your 70sSupplement needs shift meaningfully across decades as physiological priorities change. In the 40s, mitochondrial and cardiovascular foundations matter most. In the 50s and 60s, muscle preservation and bone density become critical. In the 70s, anti-inflammatory and immune support take priority.
Feb 11, 2026Pterostilbene vs Resveratrol: Bioavailability, Sirtuin Activation, and Evidence ComparisonPterostilbene is a methylated resveratrol analog with substantially better oral bioavailability. It activates SIRT1 and AMPK, lowers blood pressure in some trials, but has fewer published human studies than resveratrol. The trade-off between bioavailability and evidence depth is real.
Feb 11, 2026Supplement Bioavailability: Why Form Matters — Liposomal, Micronized, and Phospholipid ComplexesSupplement form dramatically affects how much active compound reaches target tissues. Curcumin absorption varies 20-fold between formulations. Liposomal vitamin C significantly exceeds standard ascorbic acid at equivalent doses. This guide explains the science and helps readers identify when form genuinely matters vs. marketing.
Feb 10, 2026Drug-Supplement Interactions: Warfarin, Statins, Metformin, and SSRIs — Common ConcernsMany commonly used supplements interact with medications — some significantly. Vitamin K interacts with warfarin. CoQ10 may modulate statin effects. Fish oil affects bleeding risk. NAC interacts with nitroglycerin. This guide maps the most clinically relevant interactions for the common longevity supplement stack.
Feb 10, 2026Exercise Mimetics: Can Supplements Replace Movement? AICAR, Resveratrol, and Irisin EvidenceExercise produces benefits through AMPK activation, BDNF upregulation, and irisin release that no supplement fully replicates. Some compounds (resveratrol, AICAR) partially activate overlapping pathways in animals. Human evidence for exercise replacement is weak. This article separates marketing from mechanism.
Feb 10, 2026Nicotinamide Riboside and Nicotinamide: NAD+ Precursor Comparison and Human Trial EvidenceNicotinamide riboside (NR) and plain nicotinamide both raise NAD+ but through different pathways and with different safety profiles. NR has more published human trials; nicotinamide is cheaper but raises sirtuin-inhibition concerns at high doses.
Feb 10, 2026NMN and Brain Aging: Preclinical Signal and Human Trial UncertaintyNMN is a NAD+ precursor with strong mechanistic rationale and preclinical signal, but current human cognition data remain mixed and incomplete.
Feb 10, 2026Resveratrol Protocols in Longevity Clinics: Evidence, Dosing, and Safety ContextHow longevity clinics structure resveratrol protocols and what current human evidence does and does not support.
Feb 10, 2026Sex Differences in Supplement Response: Iron, Creatine, Hormonal Context, and What Research ShowsBiological sex affects supplement needs and responses in meaningful ways. Iron requirements differ substantially. Creatine response patterns differ between sexes. Hormonal context (menstrual cycle, menopause, testosterone) affects supplement efficacy and safety profile.
Feb 9, 2026Apigenin: CD38 Inhibition, NAD+ Preservation, and Sleep EvidenceApigenin inhibits CD38, an enzyme that consumes NAD+ — positioning it as an indirect NAD booster. It also has mild sleep-promoting and senolytic properties. Human evidence is limited but mechanistic rationale is solid.
Feb 9, 2026Calcium Alpha-Ketoglutarate and Epigenetic Aging: Biological Age Reduction EvidenceCalcium alpha-ketoglutarate (Ca-AKG) is an intermediate in the Krebs cycle and an alpha-ketoglutarate-dependent dioxygenase co-factor critical for epigenetic regulation. A clinical trial showed an 8-year reduction in biological age by DNA methylation clock. Evidence is early but striking.
Feb 9, 2026NAD+ Booster Comparison: NMN vs NR vs Nicotinamide — Absorption, Price, Evidence, and Practical ChoiceThree main NAD+ precursors dominate the market: NMN, NR, and nicotinamide (NAM). Each enters the NAD+ biosynthetic pathway at different points. Human trial data exist for all three. Cost and evidence quality vary substantially. This practical comparison helps readers choose rationally.
Feb 9, 2026Supplement Timing and Dosing: When Evidence Shows It Matters — Fat-Soluble, Circadian, and Meal ContextFor most supplements, timing has modest impact. For fat-soluble vitamins (D, K, E, A), a fatty meal meaningfully improves absorption. For melatonin, CoQ10, and some adaptogens, circadian timing matters. For creatine and protein, peri-workout timing is relevant.
Feb 8, 2026The Antioxidant Network: Vitamin C, E, Glutathione, and Astaxanthin — Recycling and SynergiesAntioxidants function as a network, recycling each other rather than acting independently. Vitamin C regenerates vitamin E. Glutathione regenerates both. Astaxanthin provides singlet oxygen quenching in lipid membranes. Understanding the network prevents both under-dosing and counterproductive over-supplementation.
Feb 8, 2026Dasatinib + Quercetin Senolytic Protocol: Intermittent Dosing, Safety, and Clinical Trial EvidenceThe dasatinib + quercetin (D+Q) combination is the most clinically studied senolytic protocol. Mayo Clinic trials show clearance of senescent cells and functional improvements. Dasatinib is a chemotherapy drug with significant side effects — this is not a casual intervention.
Feb 8, 2026Mitochondria and Aging: Bioenergetics, ROS, Fission/Fusion Dynamics, and Intervention TargetsMitochondrial dysfunction is a central hallmark of aging. ATP production efficiency declines, ROS production increases, and the balance of fission (fragmentation) and fusion (elongation) shifts unfavorably. This article explains the biology and maps interventions — from CoQ10 to urolithin A — to specific mitochondrial nodes.
Feb 8, 2026Supplement Quality and Third-Party Testing: USP, NSF, Informed Sport — How to Evaluate BrandsThe supplement industry is largely unregulated in the US. Third-party certification programs (USP, NSF International, Informed Sport) verify label accuracy and contamination testing. This guide explains what each certification covers and its limitations.
Feb 7, 2026Acarbose and Longevity: ITP Lifespan Data, Postprandial Glucose Control, and Gut Microbiome EffectsAcarbose extended lifespan in male mice more than any other drug in the ITP study. Its alpha-glucosidase inhibition reduces postprandial glucose spikes and feeds colonic bacteria, improving microbiome composition. Human longevity use is off-label and based on mechanistic extrapolation.
Feb 7, 2026Building a Personalized Supplement Protocol: How to Start, What to Track, and When to AdjustMost supplement protocols fail not from wrong choices but from poor implementation — starting too many at once, not tracking outcomes, and never adjusting. This guide provides a systematic approach: baseline testing, single-variable changes, outcome tracking, and review cycles.
Feb 7, 2026NAD+ Biology: Age-Related Decline, PARP and CD38 Consumption, and Precursor InterventionsNAD+ declines 40-60% between young adulthood and old age due to increased consumption by PARP (DNA repair), CD38 (inflammatory enzyme), and reduced biosynthesis. This article explains the mechanisms, why precursor supplementation may help, and the current state of human evidence.
Feb 7, 2026Nitric Oxide and Vascular Health: Beetroot, Citrulline, and Aged Garlic — Evidence ReviewNitric oxide (NO) production declines with age, contributing to arterial stiffness, reduced exercise capacity, and cardiovascular risk. Beetroot nitrate, citrulline, and aged garlic work through complementary NO-enhancing pathways. Stacking them is rational and supported by independent trial evidence.
Feb 6, 2026Autophagy Activation Strategies: Spermidine, Fasting, and Exercise — Evidence and ProtocolAutophagy — the cellular recycling process critical for longevity — is activated by caloric restriction, fasting, exercise, and spermidine. This article maps the evidence for each approach, how they interact, and what practical protocols look like when combining these strategies.
Feb 6, 2026Berberine and AMPK: Metabolic Health, Blood Sugar, Lipids, and Comparison to MetforminBerberine activates AMPK through mechanisms similar to metformin and shows comparable glucose-lowering effects in head-to-head trials. Lipid-lowering effects are also well-supported. Bioavailability is limited but DHBerberine improves absorption.
Feb 6, 2026Cellular Senescence: What Zombie Cells Are, Senolytics, and the Evidence TimelineSenescent cells — sometimes called zombie cells — accumulate with age, secreting inflammatory signals (SASP) that damage neighboring tissue. Senolytics selectively eliminate them. This explainer covers the biology, the Mayo Clinic trials, and the current state of senolytic supplements and drugs.
Feb 5, 2026Metformin for Longevity: TAME Trial, Off-Label Use in Non-Diabetics, Safety, and ContraindicationsMetformin activates AMPK and has extensive epidemiological longevity data from diabetic populations. The TAME trial will provide the first RCT data for longevity in non-diabetics. Off-label use has meaningful risks including vitamin B12 depletion, GI effects, and contraindications.
Feb 5, 2026Mitochondrial Health Stack: CoQ10, PQQ, Carnitine, ALA, and Urolithin A — Synergies and EvidenceA comprehensive mitochondrial support protocol addresses electron transport (CoQ10), fatty acid transport (carnitine), biogenesis (PQQ, urolithin A), and antioxidant protection (ALA). Each supplement addresses a different node in mitochondrial biology. Stacking rationale is strong, though direct synergy evidence in humans is limited.
Feb 4, 2026Anti-Inflammatory Supplement Comparison: Curcumin vs Boswellia vs Omega-3 vs GingerThe four most clinically studied anti-inflammatory supplements work through different molecular targets. Omega-3 resolves inflammation via resolvins and protectins. Curcumin inhibits NF-kB and COX-2. Boswellia inhibits 5-LOX. Ginger modulates multiple pathways. Combining agents may provide additive effects.
Feb 4, 2026The 12 Hallmarks of Aging: Which Supplements Address Each and the EvidenceThe 12 hallmarks of aging — from genomic instability to chronic inflammation — each represent targetable mechanisms. This article maps which supplements have mechanistic or clinical evidence for each hallmark, providing an evidence-calibrated framework for building a longevity protocol.
Feb 4, 2026Resveratrol and SIRT1: Longevity Pathway Activation, Human Trial Disappointments, and ContextResveratrol activated enormous interest as a SIRT1 activator after early animal data. Human trials have been largely disappointing for longevity endpoints. Benefits in specific metabolic contexts (glucose tolerance, inflammation) are more supported. Understanding the gap between mechanism and human outcome is essential.
Feb 4, 2026Sleep Optimization Beyond Melatonin: Magnesium, Apigenin, CBT-I, and Light HygieneMelatonin is one of many sleep tools. Magnesium glycinate, apigenin (chamomile extract), and glycine have separate evidence bases. Cognitive-behavioral therapy for insomnia (CBT-I) outperforms all supplements for chronic insomnia. Combining behavioral and supplement approaches is rational.
Feb 3, 2026Cognitive Enhancement Stacks: Lion's Mane vs Bacopa vs Citicoline vs PS vs ALCAR — Evidence ComparisonFive well-studied cognitive supplements work through distinct mechanisms. This article compares evidence quality, time-to-effect, practical considerations, and optimal combinations for lion's mane (NGF), bacopa (memory consolidation), citicoline (choline), phosphatidylserine (membrane), and acetyl-L-carnitine (mitochondrial).
Feb 3, 2026Eye Health and Macular Degeneration Prevention: AREDS2 Formula, Lutein, and ZeaxanthinAge-related macular degeneration (AMD) is the leading cause of vision loss in older adults. The AREDS2 trial established that high-dose lutein, zeaxanthin, vitamins C and E, and zinc slow progression in intermediate-to-advanced AMD. Prevention evidence for early-stage disease is less definitive.
Feb 3, 2026Fisetin as a Senolytic: Zombie Cell Clearance, Mayo Clinic Data, and Dosing EvidenceFisetin is the most potent natural senolytic identified in preclinical studies. The Mayo Clinic demonstrated senescent cell clearance in human adipose tissue. Clinical protocols use intermittent high-dose cycles. Human evidence is early but promising.
Feb 3, 2026Magnesium L-Threonate and Brain Health: Evidence from Human TrialsMagnesium L-threonate was developed to improve brain magnesium delivery. Human trials show modest cognitive improvements in older adults, though sample sizes are small and independent replication is limited.
Feb 2, 2026Immune Resilience in Aging: Zinc, Vitamin D, Vitamin C, and Elderberry — Evidence GradientImmunosenescence — the age-related decline in immune function — increases infection risk and reduces vaccine efficacy. Zinc and vitamin D deficiency correction has clear evidence. Vitamin C has moderate support. Elderberry evidence for acute illness is positive but limited for long-term immune maintenance.
Feb 2, 2026Muscle Preservation Supplements: Protein vs EAAs vs HMB vs Creatine — Head-to-Head EvidenceFour categories of supplements target muscle preservation through different mechanisms. This article compares the evidence, practical trade-offs, and optimal use cases for protein/EAAs (anabolic substrate), creatine (phosphocreatine pool), HMB (anti-catabolic), and leucine (anabolic signaling) in older adults.
Feb 2, 2026Spermidine and Autophagy: Food Sources vs Supplementation, Human Evidence, and Longevity DataSpermidine is the most studied dietary autophagy inducer. Human observational data link higher spermidine intake to reduced all-cause mortality. Supplementation trials are emerging. Wheat germ and other foods provide meaningful amounts but supplements offer dose precision.
Feb 1, 2026Exercise Performance in Aging Adults: Creatine, Citrulline, Beta-Alanine, and What Evidence SupportsOlder adults show a different ergogenic response than younger athletes. Creatine preserves muscle mass and strength. Citrulline improves nitric oxide-dependent exercise capacity. Beta-alanine helps endurance efforts. Protein timing matters more with age.
Feb 1, 2026Rapamycin and mTOR: Longevity Mechanism, PEARL Trial, and Low-Dose Protocol RisksRapamycin extends lifespan in every organism tested and the PEARL trial is the first human RCT for longevity use. mTOR inhibition reduces cellular senescence and improves immune function. Off-label use carries real risks that must be understood before consideration.
Jan 31, 2026Gut Health and Microbiome Optimization: Fiber, Prebiotics, Probiotics, and Testing OptionsThe gut microbiome influences metabolic health, immune function, and even cognitive and mental health. Evidence supports dietary fiber as the primary driver of microbiome diversity. Targeted probiotics have strain-specific evidence for IBS, antibiotic recovery, and immune support.
Jan 31, 2026NMN vs NR vs Niacin: NAD+ Precursor Comparison, Human Data, and Practical ChoiceNMN and NR both raise NAD+ levels in humans, but mechanistic differences, tissue-specific uptake, and cost vary significantly. Head-to-head human data are limited. This article compares the available evidence and practical considerations for choosing a NAD+ precursor.
Jan 30, 2026Melatonin Beyond Sleep: Antioxidant Role, Circadian Health, and Mitochondrial Protection in AgingMelatonin production declines with age, affecting not just sleep but also circadian gene regulation, mitochondrial antioxidant defense, and neuroinflammation. Evidence is strongest for sleep; antioxidant and longevity roles are plausible but less clinically established.
Jan 30, 2026Osteoarthritis and Supplements: Curcumin, Boswellia, Glucosamine — Evidence vs PlaceboOsteoarthritis supplement evidence is mixed. Curcumin and boswellia show consistent anti-inflammatory benefit. Glucosamine evidence is ambiguous — some trials show structural benefit, others don't. This article maps what evidence supports at realistic doses.
Jan 29, 2026Bone Density Decline: D3, K2, Protein, Weight-Bearing Exercise, and DEXA MonitoringBone density peaks in the late 20s and declines gradually — accelerating in women after menopause. An evidence-based protocol combines adequate calcium, vitamin D3, vitamin K2, and protein with weight-bearing exercise and regular DEXA monitoring.
Jan 29, 2026Magnesium L-Threonate and Brain Aging: Synaptic Plasticity, Magtein Evidence, and AnxietyMagnesium L-threonate was developed specifically to raise brain magnesium levels. Animal data show impressive synaptic plasticity and memory improvements. Human trials are fewer but suggest cognitive benefits and anxiety reduction in older adults.
Jan 28, 2026Cognitive Decline Prevention: 12 Evidence-Based Domains and the FINGER Trial FrameworkThe FINGER trial demonstrated that a multimodal intervention (diet, exercise, cognitive training, vascular monitoring) significantly slowed cognitive decline. This article maps 12 modifiable domains and the supplements with strongest supporting evidence.
Jan 28, 2026LionLion's mane (Hericium erinaceus) contains hericenones and erinacines that stimulate nerve growth factor (NGF) synthesis. Human trials show improvements in mild cognitive impairment, though optimal extract form and dose are still being established.
Jan 27, 2026Alpha-GPC: Bioavailable Choline, Cognitive Aging, and Acetylcholine SupportAlpha-GPC is the most bioavailable choline supplement and crosses the blood-brain barrier effectively. Clinical trials show improvements in cognitive function in older adults with mild cognitive impairment. Often preferred over citicoline for acute cognitive enhancement.
Jan 27, 2026Sarcopenia and Muscle Preservation: Protein Targets, Resistance Training, Creatine, and HMBSarcopenia — age-related muscle loss — begins in the 4th decade and accelerates after 60. A multimodal protocol combining adequate protein (1.2-1.6g/kg/day), progressive resistance training, and targeted supplements like creatine and HMB shows the best outcomes.
Jan 26, 2026Managing Chronic Inflammation: Multi-Modal Protocol with Supplements, Diet, Sleep, and ExerciseChronic low-grade inflammation drives aging-related disease across multiple organ systems. An evidence-based protocol combines dietary modification, omega-3 supplementation, sleep optimization, exercise, and targeted anti-inflammatory compounds.
Jan 26, 2026Non-Alcoholic Fatty Liver (MASLD): Silymarin, NAC, Berberine — Evidence ReviewMASLD (metabolic dysfunction-associated steatotic liver disease, formerly NAFLD) affects an estimated 25% of adults globally. Caloric deficit and exercise remain primary. Silymarin (milk thistle), NAC, and berberine have credible supporting evidence with consistent improvements in liver enzyme markers.
Jan 26, 2026PQQ (Pyrroloquinoline Quinone): Mitochondrial Biogenesis, NGF Upregulation, and Evidence QualityPQQ stimulates mitochondrial biogenesis via PGC-1alpha and upregulates nerve growth factor (NGF). Human trial evidence is limited but suggests improvements in cognitive function and sleep quality. Often stacked with CoQ10.
Jan 25, 2026Acetyl-L-Carnitine (ALCAR) and Brain Aging: Evidence, Mechanism, and Nerve HealthAcetyl-L-carnitine (ALCAR) crosses the blood-brain barrier and supports acetylcholine synthesis and mitochondrial function in neurons. Evidence supports mild cognitive decline and peripheral neuropathy. ALCAR differs importantly from L-carnitine in CNS access.
Jan 25, 2026Lipid Management: Omega-3, Red Yeast Rice Context, Plant Sterols, and Evidence ReviewNatural lipid management is most effective for triglycerides (omega-3) and LDL reduction (plant sterols, soluble fiber). Red yeast rice contains naturally occurring statins and shares their side effect profile. The evidence hierarchy matters when deciding between lifestyle, supplements, and medications.
Jan 24, 2026Citicoline (CDP-Choline): Acetylcholine Synthesis, Brain Energy, and Stroke RecoveryCiticoline provides both choline (for acetylcholine) and cytidine (converted to uridine, a phosphatidylcholine precursor). Evidence supports cognitive protection after stroke and modest improvements in age-related cognitive decline.
Jan 24, 2026Homocysteine and Methylation: B12, Folate, TMG — Cardiovascular Risk and ProtocolElevated homocysteine is an independent cardiovascular and cognitive risk factor. The methylation pathway requires adequate B12, folate (as methylfolate in MTHFR variants), and TMG as a methyl donor. Correction is straightforward when deficiency is identified.
Jan 24, 2026L-Theanine: Caffeine Synergy, Anxiety Reduction, and Sleep Quality EvidenceL-theanine promotes calm focus without sedation. The 2:1 theanine:caffeine combination is one of the best-studied nootropic stacks, consistently improving attention and reducing caffeine jitteriness. Standalone evidence for anxiety and sleep is promising but less robust.
Jan 23, 2026Bacopa Monnieri and Memory: Bacosides, Cognitive Aging, and 12-Week RCT EvidenceBacopa monnieri improves memory consolidation and information processing in older adults. Consistent effects require 8-12 weeks of daily use. Bacosides A and B are the primary active compounds. GI side effects occur at higher doses.
Jan 23, 2026Blood Sugar and Glycation Management: Berberine, ALA, Chromium, and CarnosineElevated blood glucose accelerates aging through glycation (AGE formation), oxidative stress, and inflammation. Berberine and alpha-lipoic acid have strong glucose-lowering evidence. Carnosine and benfotiamine target the downstream glycation process. A comprehensive protocol addresses multiple pathways.
Jan 23, 2026Sulforaphane and NRF2: Broccoli Sprout Extract, Detoxification, and Cancer Prevention EvidenceSulforaphane is the most potent food-derived NRF2 activator. Broccoli sprout extract concentrates glucoraphanin (sulforaphane precursor) while myrosinase is needed for conversion. Clinical evidence for cancer chemoprevention and detoxification support is emerging.
Jan 22, 2026Arterial Stiffness Interventions: Cocoa Flavanols, Nitrates, Aged Garlic, and RCT OutcomesArterial stiffness (measured as pulse wave velocity) is an independent cardiovascular risk factor that increases with age. Cocoa flavanols, dietary nitrates, and aged garlic extract each show significant reductions in RCTs. Lifestyle factors (exercise, sodium restriction) remain foundational.
Jan 22, 2026Glycine: Collagen Synthesis, Sleep Quality RCTs, and Methylation SupportGlycine is conditionally essential in older adults. RCTs show meaningful improvement in sleep quality and morning alertness at 3g doses. It is also the rate-limiting substrate for collagen synthesis and a methyl group buffer in methylation pathways.
Jan 21, 2026Taurine and Aging: Depletion with Age, Cardiovascular Evidence, and Longevity ResearchTaurine levels decline with age and the ICV mouse study showed lifespan extension with supplementation. Human cardiovascular evidence (blood pressure, heart function) is modest but consistent. The longevity case is promising but not yet established in humans.
Jan 21, 2026Visceral Fat Reduction: Berberine, GLP-1 Context, Diet, and Exercise — Evidence ReviewVisceral adipose tissue is metabolically active and a major driver of chronic disease. Caloric deficit and exercise are primary — supplements like berberine and chromium provide meaningful but adjunctive support. GLP-1 context is relevant for clinical framing.
Jan 20, 2026Astaxanthin: Marine Carotenoid, Oxidative Stress, and Exercise Recovery EvidenceAstaxanthin is a potent marine carotenoid with evidence for reducing exercise-induced oxidative stress and muscle damage markers. Its lipophilic structure and singlet oxygen quenching capacity make it notably effective compared to other antioxidants.
Jan 20, 2026Blood Pressure: Natural Interventions — Potassium, Magnesium, Beetroot Nitrate, and DASHLifestyle and supplement approaches to blood pressure are evidence-supported and often underused. Potassium intake, dietary magnesium, beetroot nitrate, and the DASH dietary pattern each have RCT-level evidence for modest but meaningful blood pressure reduction.
Jan 19, 2026Cardiovascular Protection Supplement Stack: Omega-3, CoQ10, Garlic, and Cocoa FlavanolsA rational cardiovascular supplement stack addresses inflammation (omega-3), mitochondrial function (CoQ10), blood pressure and endothelial function (aged garlic, cocoa flavanols). This article maps the evidence for each component and how to prioritize them.
Jan 19, 2026Whey Protein Isolate for Sarcopenia: Leucine Content, Absorption, and Comparison to CaseinWhey protein's high leucine content and rapid absorption profile make it the most studied and best-supported protein supplement for muscle protein synthesis in aging. Isolate avoids lactose issues in those who are lactose intolerant.
Jan 18, 2026Essential Amino Acids for Muscle Synthesis: Leucine Threshold and Timing in Older AdultsEssential amino acids — particularly the leucine-rich profile — are the primary drivers of muscle protein synthesis. Older adults have a higher leucine threshold due to anabolic resistance, making EAA timing and quantity especially important.
Jan 17, 2026Beta-Alanine and Carnosine Buffering: Endurance Evidence, Dosing, and Paresthesia ManagementBeta-alanine raises muscle carnosine, a pH buffer that delays fatigue during high-intensity exercise. Evidence is strong for efforts lasting 1-4 minutes. Paresthesia (tingling) is harmless and manageable with split dosing.
Jan 16, 2026Citrulline Malate and Nitric Oxide: Exercise Performance Evidence in Older AdultsCitrulline raises plasma arginine and nitric oxide more efficiently than arginine supplementation. Human trials show improvements in exercise capacity, blood pressure, and endurance, particularly relevant for older adults with declining NO production.
Jan 15, 2026HMB (Beta-Hydroxy Beta-Methylbutyrate): Muscle Preservation in Aging, Evidence and DosingHMB is a leucine metabolite that reduces muscle protein breakdown. Evidence is strongest in untrained, older, and catabolic populations. Benefits in trained individuals are smaller and less consistent.
Jan 14, 2026Zinc Supplementation: Immune Function, Deficiency Detection, and Optimal FormsZinc deficiency is common in older adults and impairs innate and adaptive immunity. Supplementation in deficient individuals shows clear benefit; excess zinc is counterproductive and can displace copper.
Jan 13, 2026Phosphatidylserine for Cognitive Aging: Memory Decline, Evidence Grade, and PS+DHA SynergyPhosphatidylserine has FDA-qualified health claim status for cognitive aging. Older trials with bovine-derived PS showed consistent memory benefits; soy-derived PS effects are smaller but still meaningful.
Jan 12, 2026Rhodiola Rosea for Fatigue: SHR-5 Extract, RSSM Trials, and Adaptogen EvidenceRhodiola rosea (SHR-5 extract) has the most consistent human evidence of any adaptogen for reducing fatigue and improving stress tolerance. Effect sizes are modest but reproducible across multiple RCTs.
Jan 11, 2026Green Tea EGCG: Metabolic Effects, Longevity Pathways, and BioavailabilityEGCG (epigallocatechin gallate) is green tea's primary bioactive catechin. Evidence supports modest effects on body composition, insulin sensitivity, and cardiovascular markers, though bioavailability from supplements varies significantly.
Jan 10, 2026Alpha-Lipoic Acid: Metabolic Health, Peripheral Neuropathy, and R-ALA vs Racemic FormsAlpha-lipoic acid has the strongest evidence base in peripheral neuropathy (including diabetic neuropathy) where IV and high-dose oral formulations show consistent benefit. Metabolic effects are real but smaller.
Jan 9, 2026Ashwagandha for Stress and Cortisol: KSM-66, Sensoril, and RCT OutcomesAshwagandha (KSM-66 and Sensoril extracts) reduces serum cortisol and perceived stress scores in multiple RCTs. Effect sizes are moderate and consistent across trials, though study durations are short.
Jan 8, 2026Urolithin A and Mitophagy: Direct Supplementation vs Pomegranate, Evidence ReviewUrolithin A is the most clinically studied mitophagy activator in humans. Amazentis trials show improved muscle function and mitochondrial biomarkers in older adults. Diet alone rarely produces adequate levels.
Jan 7, 2026Vitamin K2 and Arterial Calcification: MK-4 vs MK-7, Bone and Vascular HealthVitamin K2 activates Matrix Gla Protein, which inhibits arterial calcification, and osteocalcin for bone mineralization. MK-7 has superior half-life and bioavailability vs MK-4.
Jan 6, 2026NAC (N-Acetylcysteine): Glutathione Precursor, Liver Support, and Respiratory EvidenceNAC is the most established glutathione precursor supplement with strong evidence in clinical acetaminophen toxicity and COPD exacerbations. General longevity use has weaker but plausible support.
Jan 5, 2026Curcumin and Chronic Inflammation: Evidence, Dosing, and BioavailabilityCurcumin reduces inflammatory markers in multiple RCTs, but poor oral bioavailability limits standard formulations. Piperine co-dosing and liposomal forms substantially improve absorption.